Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells

作者: H M Aliabadi , P Mahdipoor , H Uludağ

DOI: 10.1038/CGT.2013.8

关键词:

摘要: Enhanced survival mechanisms of malignant cells in combination with elevated levels drug transporters can sustain an undesirable resistance against therapy. Short interfering RNA (siRNA) delivery targets involved aberrant is a promising approach and we hypothesize that simultaneous silencing multiple could prove more advantageous than common to silence individual targets. To explore this approach, targeted anti-apoptotic proteins myeloid cell leukemia 1 (Mcl-1) survivin along the efflux pump P-glycoprotein (P-gp) drug-resistant breast cancer cells. Polymeric siRNA was employed for purpose by using small polyethylenimine (PEI) substituted lipids. While Mcl-1 caused ∼90% death wild-type cells, effect less significant P-gp over-expressing An additive evident latter where these created significantly higher compared each target. Prolonged exposure doxorubicin (DOX) resulted upregulation P-gp, protein, Mcl-1. Dual again resistance-induced which displayed increased dependency on survival. Cytotoxic DOX also enhanced after We conclude polymer-mediated simultaneously reverse resistance.

参考文章(46)
Lawrence D. Mayer, Jennifer A. Shabbits, The role for liposomal drug delivery in molecular and pharmacological strategies to overcome multidrug resistance. Cancer and Metastasis Reviews. ,vol. 20, pp. 87- 93 ,(2001) , 10.1023/A:1013108524062
Ricky W. Johnstone, Erika Cretney, Mark J. Smyth, P-Glycoprotein Protects Leukemia Cells Against Caspase-Dependent, but not Caspase-Independent, Cell Death Blood. ,vol. 93, pp. 1075- 1085 ,(1999) , 10.1182/BLOOD.V93.3.1075
David A Norris, Yiqun G Shellman, Deborah Ribble, Nathaniel B Goldstein, A simple technique for quantifying apoptosis in 96-well plates BMC Biotechnology. ,vol. 5, pp. 12- 12 ,(2005) , 10.1186/1472-6750-5-12
Wasif N. Khan, B Cell Receptor and BAFF Receptor Signaling Regulation of B Cell Homeostasis Journal of Immunology. ,vol. 183, pp. 3561- 3567 ,(2009) , 10.4049/JIMMUNOL.0800933
Gustavo Ortiz-Ferrón, Rosario Yerbes, Adriana Eramo, Ana I López-Pérez, Ruggero De Maria, Abelardo López-Rivas, Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism. Cell Research. ,vol. 18, pp. 664- 676 ,(2008) , 10.1038/CR.2008.54
K. M. Kozopas, T. Yang, H. L. Buchan, P. Zhou, R. W. Craig, MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 3516- 3520 ,(1993) , 10.1073/PNAS.90.8.3516
D.R. Ferry, H. Traunecker, D.J. Kerr, Clinical trials of P-glycoprotein reversal in solid tumours European Journal of Cancer. ,vol. 32, pp. 1070- 1081 ,(1996) , 10.1016/0959-8049(96)00091-3
Zhi Shi, Yong-Ju Liang, Zhe-Sheng Chen, Xiao-Hong Wang, Yan Ding, Li-Ming Chen, Li-Wu Fu, Overexpression of Survivin and XIAP in MDR cancer cells unrelated to P-glycoprotein. Oncology Reports. ,vol. 17, pp. 969- 976 ,(2007) , 10.3892/OR.17.4.969
T Uziel, D Semizarov, S W Elmore, J D Leverson, L T Lam, Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines Oncogene. ,vol. 30, pp. 1963- 1968 ,(2011) , 10.1038/ONC.2010.559